End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.21 CNY | +1.61% | -.--% | +17.12% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
Sales 2024 * | 168B 23.21B | Sales 2025 * | 192B 26.45B | Capitalization | 31.26B 4.32B |
---|---|---|---|---|---|
Net income 2024 * | 2.49B 344M | Net income 2025 * | 3.26B 450M | EV / Sales 2024 * | 0.24 x |
Net Debt 2024 * | 9.24B 1.28B | Net Debt 2025 * | 12.56B 1.73B | EV / Sales 2025 * | 0.23 x |
P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
9.86
x | Employees | 30,100 |
Yield 2024 * |
3.05% | Yield 2025 * |
4.25% | Free-Float | 40.28% |
1 day | +1.61% | ||
1 month | +0.37% | ||
3 months | +19.16% | ||
6 months | +13.40% | ||
Current year | +17.12% |
Managers | Title | Age | Since |
---|---|---|---|
Wei He
CEO | Chief Executive Officer | 38 | 21-09-30 |
Chang Yun Liu
CHM | Chairman | 42 | 17-07-31 |
Ying Zheng Xu
CHM | Chairman | 51 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 62 | 20-11-04 |
Bao Lin Liu
FOU | Founder | 71 | 99-02-28 |
Zhao Nian Liu
BRD | Director/Board Member | 64 | 08-11-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 2 M€ | -12.62% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 8.21 | +1.61% | 28,492,410 |
24-04-29 | 8.08 | -1.58% | 36,545,830 |
24-04-26 | 8.21 | -.--% | 20,114,730 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.12% | 4.32B | |
+14.23% | 69.5B | |
+7.11% | 8.2B | |
-20.55% | 7.97B | |
-4.06% | 7.84B | |
+2.26% | 4.66B | |
+1.41% | 4.19B | |
-3.02% | 3.89B | |
+21.42% | 3.62B | |
+8.64% | 3.41B |
- Stock Market
- Equities
- 600998 Stock